Dr. Mohammed K. Elsayed, MD

Dr. Elsayed practices at Mohammed K Elsayed A Professional Corporation in Chula Vista, California.

Dr. Elsayed's NPI, 1821033424, was assigned on June 18, 2006. Dr. Elsayed graduated from University of Alexandria Faculty of Medicine in 1985. Dr. Elsayed holds California license A100765.

Dr. Elsayed's primary practice is Mohammed K Elsayed A Professional Corporation, at 330 Oxford St, Chula Vista, CA 91911. The practice phone is (619) 409-1802.

Dr. Elsayed's primary practice is Mohammed K Elsayed A Professional Corporation in Chula Vista, California. The medical group on file is Oxford Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elsayed practices. Vendor and product names are available with a free account.

Family medicine is Dr. Elsayed's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Elsayed is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Elsayed's licenses on file in 3 states: California, New Jersey and New York.

Dmand AI lists acute sinusitis, aneurysm, asthma, chronic diabetes, chronic hypertension, chronic kidney disease, coronary artery disease and ear infection among the conditions Dr. Elsayed treats.

CMS data shows 282 Medicare services from Dr. Elsayed across 5 procedure codes in 2024, for 56 Medicare patients. Medicare paid $19,213 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. Elsayed in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elsayed's median patient age at 50, with 54% women.

In 2024, Dr. Elsayed wrote 4,824 Medicare Part D claims for 294 patients. 80% of them were for generic drugs. CMS names the drug for 4,262 of them, across 99 drugs with 11 or more claims each, at $654,644 in total drug cost. In 2023, CMS named 4,489 claims across 103 drugs.

Dr. Elsayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elsayed as offering telehealth.

CMS Open Payments shows 116 general payments to Dr. Elsayed from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $568.

Dr. Elsayed graduated from University of Alexandria Faculty of Medicine in 1985.

Dr. Elsayed is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.